Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures

BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arq Bras Cardiol
Main Authors: Andrade, Marcus Vinicius Santos, Andrade, Luciana Azevedo Prata, Bispo, Alan Freitas, Freitas, Luana de Alencar, Andrade, Milena Quadros Sampaio, Feitosa, Gilson Soares, Feitosa-Filho, Gilson Soares
Formato: Artigo
Idioma:Inglês
Publicado em: Sociedade Brasileira de Cardiologia - SBC 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173350/
https://ncbi.nlm.nih.gov/pubmed/30088558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5935/abc.20180137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados